Iron as the Key Modulator of Hepcidin Expression in Erythroid Antibody-Mediated Hypoplasia

Figure 2

Erythrocyte data and reticulocyte count during the follow-up period of 9 weeks under rHuEPO treatment. Results are expressed as mean ± SD. versus control; versus 50 IU rHuEPO; versus control; versus 50 IU rHuEPO; versus ; versus ; versus .